Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:04 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 24 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Meridian Bioscience, Inc. Clear all

Conditions: Metabolic Syndrome, Nonalcoholic Fatty Liver Disease
Interventions: Sodium Octanoate Breath Test; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Houston, Texas • Richmond, Virginia

Conditions: Decompensated Cirrhosis
Interventions: Methacetin Breath Test, Emricasan, Placebo oral capsule; Combination Product · Drug
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Lakewood Rch, Florida

Conditions: Mycoplasma Pneumoniae
Interventions: illumigene® Mycoplasma Direct, illumipro-10; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: Not listed
Enrollment: 471 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 3
States / cities: Pensacola, Florida • Kansas City, Missouri • Fort Worth, Texas

Conditions: Cirrhosis
Interventions: Not listed
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Richmond, Virginia

Conditions: Hepatitis C
Interventions: MBT and BreathID; Other
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 4
States / cities: New York, New York • Houston, Texas • Richmond, Virginia

Conditions: Clostridium Difficile Infection
Interventions: Comparison between GenePOC PCR and Reference Method; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: Not listed
Enrollment: 2,461 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 5
States / cities: Indianapolis, Indiana • Baltimore, Maryland • Detroit, Michigan + 2 more

Conditions: Streptococcus Pneumoniae Infection, Legionella Pneumophila Serogroup 1 Infection
Interventions: N/A- There is no intervention.; Other
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: CMV
Interventions: illumigene CMV assay, illumipro-10; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: Up to 20 Days
Enrollment: 1,615 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Birmingham, Alabama • Salt Lake City, Utah

Conditions: NASH - Nonalcoholic Steatohepatitis
Interventions: ¹³C-Methacetin Breath Test, BMS-986036, BreathID MCS device; Combination Product · Drug · Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Humble, Texas

Conditions: Helicobacter Pylori Infection
Interventions: Dual Mode BreathID Hp System; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 11
States / cities: Tucson, Arizona • Ventura, California • Lafayette, Colorado + 8 more

Conditions: Hepatic Sarcoidosis, Elevated Alkaline Phosphatase
Interventions: Ursodeoxycholic Acid; Drug
Lead sponsor: Ethan Weinberg; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Suspicion of Being Infected With H.Pylori
Interventions: Modified BreathID; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: East Brunswick, New Jersey

Conditions: Non-Alcoholic Steatohepatitis
Interventions: Suspected NASH BreathID test with 13C-Octanoate, Suspected NASH Breath test with 13C Methacetin; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 8
States / cities: Chicago, Illinois • Forts Sam Houston, Texas • Houston, Texas + 3 more

Conditions: Helicobacter Pylori Infection
Interventions: BreathID® Hp System, BreathID® Hp Lab System, Stool Test; Device · Drug · Diagnostic Test
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 3 Years to 18 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 5
States / cities: Shreveport, Louisiana • Flowood, Mississippi • Nashville, Tennessee + 2 more

Conditions: Chlamydia, Gonorrhea
Interventions: illumigene CT and NG assays, illumipro-10; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 14 Years to 89 Years
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 3
States / cities: Aurora, Colorado • Fall River, Massachusetts • Philadelphia, Pennsylvania

Conditions: Cirrhosis
Interventions: BreathID (Methacetin breath test); Device
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 3
States / cities: Detroit, Michigan • Charleston, South Carolina • Richmond, Virginia

Conditions: Chronic Liver Disease
Interventions: Not listed
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 579 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 3
States / cities: Detroit, Michigan • Charleston, South Carolina • Richmond, Virginia

Conditions: Helicobacter Pylori Infection
Interventions: Breath Test Collection bags; Other
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 193 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 9
States / cities: Baltimore, Maryland • Chevy Chase, Maryland • Detroit, Michigan + 6 more

Conditions: Chronic Liver Disease
Interventions: c13 methacetin solution with breath analyzer; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 414 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 8
States / cities: Los Angeles, California • Detroit, Michigan • Cleveland, Ohio + 5 more

Conditions: Patients With Compensated Liver Cirrhosis
Interventions: Methacetin Breath Test; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 246 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 3
States / cities: New Haven, Connecticut • Durham, North Carolina • Richmond, Virginia

Conditions: Pharyngitis, Infective
Interventions: Comparison between GenePOC CR and Reference Method; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 25 Months and older
Enrollment: 497 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 5
States / cities: Madera, California • Indianapolis, Indiana • Detroit, Michigan + 2 more

Conditions: Carbapenem-Resistant Enterobacteriaceae
Interventions: Rectal swab collection; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Indianapolis, Indiana • Detroit, Michigan

Conditions: Acute Liver Failure
Interventions: 13C-Methacetin; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 11
States / cities: Birmingham, Alabama • San Francisco, California • New Haven, Connecticut + 8 more

Conditions: Streptococcus Agalactiae Infection
Interventions: Comparison between GenePOC PCR and Reference Method; Device
Lead sponsor: Meridian Bioscience, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 771 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Detroit, Michigan • Albuquerque, New Mexico

Search by objective public record fields.

Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)

Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17

Detection of Mycoplasma Pneumoniae

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

BreathID Multi-center HCV Liver Breath Test Study

Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains

Curian S. Pneumo/Legionella Assay Beta Clinical Trial Protocol

Detection of Cytomegalovirus Virus in Neonates

Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

Ursodeoxycholic Acid (UDCA) for Hepatic Sarcoidosis

Show Equivalence of the Modified BreathID Compared to Currently Approved BreathID in H.Pylori Detection

BREATHID Octanoate Breath Test With or Without Methacetin Breath Test for Correlation With Biopsy in NASH

Urea Breath Test (UBT) With Breath Hp System /BreathID Hp Lab System Pediatrics

Detection of Chlamydia (CT) and Gonorrhea (NG)

Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis

Assessing Portal Hypertension With Methacetin Breath Test

Validation of the GenePOC Strep A, C/G Assay for Detecting Group A, C and G β-hemolytic Streptococcus From Throat Swabs.

Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.

13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF

Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains